HEPA logoHEPA
Hepion Pharmaceuticals Inc

27,550
Loading...
Loading...
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Hepion Pharmaceuticals Inc?
What is the 52-week high for Hepion Pharmaceuticals Inc?
What is the 52-week low for Hepion Pharmaceuticals Inc?
What is Hepion Pharmaceuticals Inc stock price today?
What was Hepion Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Hepion Pharmaceuticals Inc?
What is the Price-to-Book ratio of Hepion Pharmaceuticals Inc?
What is the 50-day moving average of Hepion Pharmaceuticals Inc?

Latest HEPA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.